Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Deals channel feed
Dewpoint partners its ALS program, eyes JPM to raise a Series D
5 months ago
Startups
Pharma
GSK makes another ADC deal, this time with BioNTech's partner DualityBio
5 months ago
China
Pharma
Coherus makes final, $483M pivot away from biosimilars
5 months ago
Pharma
Ipsen secures rights to preclinical T cell engager in $610M pact with French biotech
5 months ago
R&D
Relay licenses cancer drug to Korean biotech for $75M
5 months ago
Takeda to pay $200M for rights to anemia drug from Keros
5 months ago
Pharma
Gilead makes another ADC move, inking up to $415M pact with Tubulis
5 months ago
Startups
Pharma
Roche teams up with Chicago autoimmune biotech COUR Pharmaceuticals
5 months ago
Pharma
Olema, Novartis ink another agreement, this time for a late-stage breast cancer trial
5 months ago
R&D
Novartis pays $1B upfront for PTC's Phase 2 Huntington's drug
5 months ago
Pharma
Acadia snaps up an essential tremor drug after field's summer setbacks
5 months ago
Startups
Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway
5 months ago
People
Sarepta licenses Arrowhead's RNA-based rare disease pipeline, promising big biobucks
6 months ago
Updated: Roche buys out CAR-T partner Poseida for $1B upfront
6 months ago
Cell/Gene Tx
Cradle Bio raises $73M Series B to sell pharma its protein-making AI software
6 months ago
AI
Gilead buys experimental HIV vaccines from a small Barcelona biotech
6 months ago
Startups
Pharma
Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'
6 months ago
Pharma
Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B
6 months ago
R&D
Kyowa Kirin acquires ex-US rights to Kura’s leukemia treatment for $330M upfront
6 months ago
23andMe inks new research partnership as it winds down internal drug development efforts
6 months ago
Health Tech
Pfizer partners with two more Flagship biotechs on obesity, cancer
6 months ago
Startups
Pharma
Novartis strikes radiopharma deal with Ratio worth up to $745M
6 months ago
Startups
Pharma
Exclusive: Athena Countouriotis' Avenzo taps Shanghai biotech for ADC, adds new funds
6 months ago
Startups
China
Evotec gains on Halozyme's takeover proposal
6 months ago
Manufacturing
First page
Previous page
6
7
8
9
10
11
12
Next page
Last page